YOLFTbeta
Anhui Anke BioTech Group

Anhui Anke BioTech Group

300009 · SHE · Healthcare / Biotechnology

7.66CNY-0.21 (-2.67%)

Price History

Full chart

Market Stats

Previous Close7.87
Open7.87
Day Range7.66 – 7.89
52-Week Range7.35 – 11.17
Volume15.92M
Market Cap14.38B
P/E (TTM)20.50
Forward P/E37.17
EPS0.42
Dividend Yield2.90%
Beta0.36
50-Day Avg8.42
200-Day Avg9.01

About

Anhui Anke Biotechnology (Group) Co., Ltd. engages in the biopharmaceutical industry in China and internationally. It offers human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. The company provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, immunohistochemical, sperm DNA fragmentation staining, leptin, and immunohistochemical diagnostic kits. In addition, it offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care products, including anti-aging, masks, essential liquids, and mouthwash; and sybthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, the company provides autosomal, sex chromosome, and other kits; paternity testing, tumor biological immunotherapy technology, and DNA testing services. Additionally, the company offers monoclonal antibody drugs, such as Trastuzumab to treat patients with breast and gastric cancers under the ANTRASTUIN brand; Bevacizumab, an anti-VFDF product; ANKEBIO anti-PD1; and anti-covid19 products. The company was founded in 2000 and is based in Hefei, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Lihua Song Ph.D.
  • Employees2.50K
  • HeadquartersAnkeBio Buildings, Hefei, China, 230088, China
  • Websitehttps://www.ankebio.com

Leadership

  • Mr. Lihua Song Ph.D.Chairman of Board of Directors & President · b. 1957
  • Mr. Chenghao HuFinancial Director & Accounting Supervisor · b. 1976
  • Mr. Yong Bin WangDirector of Operations & Director · b. 1968
  • Mr. Jian Ping YaoSenior Vice President · b. 1972
  • Mr. Hai ShengSenior Vice President · b. 1975
  • Ms. Hui ZhaoSenior VP & Director · b. 1974
  • Ms. Chunyan LuVice President · b. 1978
  • Mr. Kun LiSecretary of the Board & Director · b. 1982
  • Mr. Xian Yu DuDirector · b. 1970
  • Ms. Hongyi YaoVice President · b. 1972

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue127.77M125.87M156.49M190.64M227.93M267.92M337.94M430.35M542.41M635.76M849.22M1.10B1.46B1.71B1.70B2.17B2.33B2.87B2.54B2.65B
Growth (%)--1.48%+24.32%+21.83%+19.56%+17.54%+26.14%+27.34%+26.04%+17.21%+33.58%+29.09%+33.32%+17.17%-0.65%+27.47%+7.48%+22.94%-11.51%+4.36%
Cost of Revenue45.51M37.58M45.53M53.01M64.60M78.61M92.91M117.81M157.86M181.81M221.28M245.24M291.74M379.16M364.09M436.15M513.47M626.15M581.16M643.16M
Gross Profit82.26M88.29M110.96M137.63M163.33M189.30M245.03M312.53M384.54M453.95M627.94M851.03M1.17B1.33B1.34B1.73B1.82B2.24B1.95B2.00B
Gross Margin64.38%70.14%70.91%72.19%71.66%70.66%72.51%72.62%70.90%71.40%73.94%77.63%80.04%77.86%78.60%79.89%77.97%78.15%77.08%75.70%
Operating Expense66.67M62.04M70.50M91.88M113.05M120.05M175.48M211.49M261.87M303.81M408.92M521.98M859.18M1.17B913.29M1.44B975.59M1.32B1.15B1.16B
Operating Income15.59M26.25M40.46M45.75M50.27M69.26M69.55M101.05M122.67M150.14M219.01M329.05M310.63M165.15M424.04M297.44M841.99M923.98M806.40M841.16M
Operating Margin12.20%20.85%25.85%24.00%22.06%25.85%20.58%23.48%22.62%23.62%25.79%30.02%21.25%9.64%24.92%13.71%36.12%32.24%31.80%31.78%
EBITDA31.46M38.78M49.67M61.40M73.57M88.89M83.04M112.36M143.05M174.75M261.78M355.17M395.01M461.82M462.67M676.71M836.21M993.44M846.07M959.03M
EBITDA Margin24.62%30.81%31.74%32.20%32.28%33.18%24.57%26.11%26.37%27.49%30.83%32.40%27.03%26.97%27.19%31.20%35.87%34.67%33.36%36.24%
Net Income15.73M22.71M34.55M44.57M51.98M63.32M73.95M89.87M109.85M136.25M197.30M277.74M263.17M124.47M358.96M206.63M703.26M847.23M706.95M735.19M
Net Income Margin12.31%18.04%22.08%23.38%22.81%23.64%21.88%20.88%20.25%21.43%23.23%25.34%18.01%7.27%21.10%9.53%30.17%29.56%27.88%27.78%
R&D----9.98M22.42M23.45M26.10M29.41M35.87M51.78M70.17M87.32M120.09M126.36M166.54M166.01M254.68M214.44M219.45M
R&D as % of Total Revenue----4.38%8.37%6.94%6.06%5.42%5.64%6.10%6.40%5.97%7.01%7.43%7.68%7.12%8.89%8.46%8.29%
Interest Expense3.54M4.40M3.68M1.42M550.75K206.73K125.06K55.09K322.96K96.97K3.34M2.27M3.50M3.66M1.78M2.25M2.48M2.94M3.51M1.93M
Interest Expense % of Total Revenue2.77%3.49%2.35%0.75%0.24%0.08%0.04%0.01%0.06%0.02%0.39%0.21%0.24%0.21%0.10%0.10%0.11%0.10%0.14%0.07%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets225.72M236.55M222.96M542.36M589.55M603.65M652.93M749.81M915.58M1.39B1.97B2.25B2.53B3.23B3.53B3.67B4.26B4.95B5.14B5.55B
Total Liabilities103.72M99.46M74.32M46.95M67.25M59.77M72.91M89.21M142.11M126.48M539.04M493.73M515.86M526.19M600.29M765.52M855.17M1.02B835.41M811.30M
Total Equity110.52M125.88M148.64M495.41M519.59M543.88M580.03M660.60M738.90M1.22B1.36B1.68B1.92B2.63B2.84B2.79B3.21B3.74B4.12B4.56B
Cash31.85M43.16M32.45M338.81M336.50M258.36M217.82M230.92M181.94M89.36M152.03M134.48M145.94M527.26M248.07M322.56M324.59M260.23M299.18M250.20M
Total Debt57.70M27.00M22.05M-7.70M3.70M----60.00M50.00M100.12M14.03M20.98M23.74M27.07M47.82M43.25M-
Net Debt25.85M-16.16M-10.40M-338.81M-328.80M-254.66M-217.82M-230.92M-181.94M-89.36M-92.03M-84.48M-45.82M-513.23M-227.09M-298.82M-297.52M-212.41M-255.93M-

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow29.66M35.10M26.04M38.67M47.43M7.18M53.80M53.21M108.68M118.73M258.01M280.63M287.49M295.63M464.80M592.17M698.98M952.97M685.37M863.22M
Investing Cash Flow-2.18M-8.44M-3.64M-11.93M-15.26M-42.67M-52.76M-25.98M-152.68M-269.48M-415.32M-222.00M-214.09M-664.17M-363.35M-171.10M-543.88M-617.27M-170.25M-
Financing Cash Flow-14.85M-14.88M-32.78M279.66M-34.47M-42.75M-41.54M-13.89M-4.96M58.16M219.99M-76.17M-65.88M428.95M-126.35M-276.30M-153.15M-400.99M-475.38M-
Capital Expenditure2.57M9.32M6.52M12.54M11.18M82.54M59.42M31.64M88.04M36.95M69.18M131.78M213.72M186.48M138.52M131.23M474.34M195.34M117.22M126.89M
Free Cash Flow27.09M25.77M19.52M26.14M36.25M-75.36M-5.62M21.58M20.65M81.78M188.83M148.85M73.77M109.15M326.27M460.94M224.64M757.64M568.15M736.33M
Dividends Paid12.75M14.37M15.78M16.69M27.07M38.15M37.84M46.12M47.96M43.71M65.46M82.77M111.24M161.82M159.19M273.08M327.54M411.05M415.57M413.48M
FCF to OCF91.33%73.43%74.95%67.59%76.43%-1049.50%-10.45%40.55%19.00%68.88%73.19%53.04%25.66%36.92%70.20%77.84%32.14%79.50%82.90%85.30%
Dividend Paid to FCF47.07%55.75%80.81%63.84%74.68%-50.62%-673.30%213.73%232.32%53.44%34.67%55.61%150.80%148.25%48.79%59.24%145.81%54.25%73.15%56.15%

Earnings

Report DateAug 19, 2014Oct 21, 2014Feb 17, 2015Apr 22, 2015Aug 11, 2015Oct 25, 2015Feb 26, 2016Apr 26, 2016Aug 23, 2016Oct 25, 2016Mar 1, 2017Apr 26, 2017Aug 22, 2017Oct 25, 2017Feb 27, 2018Apr 25, 2018Aug 23, 2018Oct 29, 2018Feb 27, 2019Apr 24, 2019Aug 27, 2019Oct 24, 2019Feb 28, 2020Apr 28, 2020Aug 25, 2020Oct 28, 2020Apr 7, 2021Aug 19, 2021Oct 28, 2021Mar 30, 2022Apr 27, 2022Aug 24, 2022Oct 25, 2022Mar 27, 2023Apr 27, 2023Aug 23, 2023Oct 24, 2023Mar 27, 2024Apr 25, 2024Aug 28, 2024Oct 24, 2024Mar 27, 2025Apr 28, 2025Aug 22, 2025Oct 29, 2025Apr 27, 2026Aug 26, 2026
EPS Estimate-----------------------------------------------
EPS Actual0.020.030.020.020.030.030.020.020.030.040.040.030.040.050.050.060.060.080.030.040.050.07-0.080.050.050.080.040.070.11-0.140.110.110.150.070.110.130.160.120.130.120.110.070.130.100.110.100.10
Surprise-----------------------------------------------
TimingAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketPre-marketPre-market----

Key Statistics & Ratios

Market Cap14.38B
Enterprise Value12.84B
Trailing P/E20.50
Forward P/E37.17
PEG Ratio0.00
Price / Sales5.87
Price / Book3.32
EPS0.42
Book Value2.59
Revenue (TTM)2.45B
Gross Profit (TTM)1.83B
EBITDA879.88M
Profit Margin28.59%
Operating Margin34.69%
Return on Equity16.67%
Return on Assets9.44%
Shares Outstanding1.67B
Shares Float1.03B
Beta0.36
Dividend Yield2.90%
Dividend Rate0.25
Payout Ratio80.13%

Dividends

20261×
0.25May 29, 2026
20252×
0.15May 23, 20250.10Jan 17, 2025
20241×
0.25May 27, 2024
20231×
0.25May 19, 2023
20221×
0.20May 13, 2022
20211×
0.17May 14, 2021
20201×
0.10May 22, 2020
20191×
0.10May 9, 2019
20181×
0.07May 4, 2018
20171×
0.05May 18, 2017
20161×
0.04Apr 15, 2016
20151×
0.03Apr 17, 2015
20141×
0.03Jun 6, 2014
20131×
0.03Jun 13, 2013
20121×
0.03May 4, 2012
20111×
0.03May 6, 2011
20101×
0.02May 12, 2010

Stock Splits

  • May 14, 20211.2:1
  • May 22, 20201.3:1
  • May 4, 20181.4:1
  • May 18, 201713:10
  • Apr 15, 201613:10
  • Apr 17, 201513:10
  • Jun 6, 201412:10
  • Jun 13, 20131.2437:1
  • May 6, 201112.5:10
  • May 12, 201018:10